Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Carrageenan-based microbicide PC-710 described at AIDS conference

July 10, 2002

Breakthrough AIDS treatment ready for phase II clinical trials

July 10, 2002

Atazanavir shows a better lipid profile than nelfinavir in HIV-infected patients

July 9, 2002

HE-2000 effects on immune parameters, inflammatory gene expression and viremia in HIV

July 9, 2002

Preclinical profile of PA-457, a betulinic acid derivative, discussed this week at AIDS conference

July 9, 2002

Immunotherapeutic potential of tucaresol in HIV suggested by pilot study results

July 9, 2002

Prous Science webcasts over 20 hours of official sessions of the 14th International AIDS Conference

July 8, 2002

VaxGen and Genentech revise AIDS vaccine candidate agreement

July 5, 2002

T-1249 shows anti-HIV activity in phase I/II trial

July 4, 2002

Takeda reports novel CCR5 antagonists and their use in HIV infection

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...